Protection from diabetes-induced atherosclerosis and renal disease by d-carnosine-octylester: effects of early vs late inhibition of advanced glycation end-products in Apoe-null mice

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Diabetologia

• Publication date

  2015-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00125-014-3467-6PMID 25471794
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Higher levels of advanced glycation endproducts in human carotid atherosclerotic plaques are associated with a rupture-prone phenotype.

  2014cited by this paper
• Derivative of Bardoxolone Methyl, dh404, in an Inverse Dose-Dependent Manner Lessens Diabetes-Associated Atherosclerosis and Improves Diabetic Kidney Disease

  2014cited by this paper
• Advanced glycated end-products affect HIF-transcriptional activity in renal cells.

  2013cited by this paper
• D‐carnosine octylester attenuates atherosclerosis and renal disease in ApoE null mice fed a Western diet through reduction of carbonyl stress and inflammation

  2012influential reference
• The carbonyl scavenger carnosine ameliorates dyslipidaemia and renal function in Zucker obese rats

  2010cited by this paper
• Design, Synthesis, and Evaluation of Carnosine Derivatives as Selective and Efficient Sequestering Agents of Cytotoxic Reactive Carbonyl Species

  2009cited by this paper
• Accelerated Lipid-Induced Atherogenesis in Galectin-3–Deficient Mice: Role of Lipoxidation via Receptor-Mediated Mechanisms

  2009cited by this paper
• Megatrials in type 2 diabetes. From excitement to frustration?

  2009cited by this paper
• Glucose control and vascular complications in veterans with type 2 diabetes.

  2009cited by this paper
• Reduction of renal superoxide dismutase in progressive diabetic nephropathy.

  2009cited by this paper
• UKPDS and the legacy effect.

  2008cited by this paper
• Transition metal ion binding studies of carnosine and histidine: biologically relevant antioxidants.

  2008cited by this paper
• The role of advanced glycation end products in progression and complications of diabetes

  2008cited by this paper
• Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitors

  2008cited by this paper
• 10-year follow-up of intensive glucose control in type 2 diabetes.

  2008cited by this paper
• Review of an article: The ADVANCE Collaborative Group. (2008). Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes. NEJM 2008;358:2560-2572.

  2008cited by this paper
• Effects of intensive glucose lowering in type 2 diabetes.

  2008cited by this paper
• Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.

  2008cited by this paper
• Ablation of the gene encoding p66Shc protects mice against AGE-induced glomerulopathy by preventing oxidant-dependent tissue injury and further AGE accumulation

  2007cited by this paper
• Reactive carbonyls and oxidative stress: potential for therapeutic intervention.

  2007cited by this paper
• Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial.

  2006cited by this paper
• Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.

  2005cited by this paper
• Carnosine and related dipeptides as quenchers of reactive carbonyl species: From structural studies to therapeutic perspectives

  2005cited by this paper
• Advanced glycation endproducts--role in pathology of diabetic complications.

  2005cited by this paper
• Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes.

  2004cited by this paper
• Galectin‐3/AGE‐receptor 3 knockout mice show accelerated AGE‐induced glomerular injury: evidence for a protective role of galectin‐3 as an AGE receptor

  2004cited by this paper
• Overview of glucose signaling in mesangial cells in diabetic nephropathy.

  2003cited by this paper
• l-carnosine and verapamil inhibit hypoxia-induced expression of hypoxia inducible factor (HIF-1 alpha) in H9c2 cardiomyoblasts.

  2002cited by this paper
• A Procedure for Obtaining Whole Mount Mouse Aortas that Allows Atherosclerotic Lesions to be Quantified

  2001cited by this paper
• Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice.

  2000cited by this paper
• A re-evaluation of the antioxidant activity of purified carnosine.

  2000cited by this paper
• Peroxisome proliferator–activated receptor γ ligands inhibit development of atherosclerosis in LDL receptor–deficient mice

  2000cited by this paper
• Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients.

  2000cited by this paper
• Reversal of lesions of diabetic nephropathy after pancreas transplantation.

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Activation of the Receptor for Advanced Glycation End Products Triggers a p21 ras -dependent Mitogen-activated Protein Kinase Pathway Regulated by Oxidant Stress*

  1997cited by this paper
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper
• Antigen markers of macrophage differentiation in murine tissues.

  1992cited by this paper

• Histidine‐Containing Dipeptides in Obesity and Cardiometabolic Health: A Systematic Scoping Review

  2025cites this paper
• Preclinical evidence and therapeutic perspectives on carnosine for the treatment of neurodegenerative disorders

  2025cites this paper
• Renal Expression and Localization of the Receptor for (Pro)renin and Its Ligands in Rodent Models of Diabetes, Metabolic Syndrome, and Age-Dependent Focal and Segmental Glomerulosclerosis

  2024cites this paper
• Protective effect of SERCA2a-SUMOylation by SUMO-1 on diabetes-induced atherosclerosis and aortic vascular injury

  2024cites this paper
• Histidine containing dipeptides protect epithelial and endothelial cell barriers from methylglyoxal induced injury

  2024cites this paper
• A comprehensive review on physiological and biological activities of carnosine: turning from preclinical facts to potential clinical applications

  2024cites this paper
• Novel Approaches to the Management of Diabetes Mellitus in Patients with Coronary Artery Disease.

  2023cites this paper
• HDL Function and Atherosclerosis: Reactive Dicarbonyls as Promising Targets of Therapy

  2023cites this paper
• The therapeutic potential of carnosine: Focus on cellular and molecular mechanisms

  2023cites this paper
• Carnosine Did Not Affect Vascular and Metabolic Outcomes in Patients with Prediabetes and Type 2 Diabetes: A 14-Week Randomized Controlled Trial

  2023cites this paper
• Endogenous Protective Factors and Potential Therapeutic Agents for Diabetes-Associated Atherosclerosis

  2022cites this paper
• Carnosine as a potential therapeutic for the management of peripheral vascular disease.

  2022cites this paper
• Isopropyl-naphthylamide-hydrazine as a Novel Fluorescent Reagent for Ultrasensitive Determination of Carbonyl Species on UPLC

  2022cites this paper
• Mutual Regulation between Redox and Hypoxia-Inducible Factors in Cardiovascular and Renal Complications of Diabetes

  2022influential citation
• Food-Related Carbonyl Stress in Cardiometabolic and Cancer Risk Linked to Unhealthy Modern Diet

  2022cites this paper
• Normalizing HIF-1α Signaling Improves Cellular Glucose Metabolism and Blocks the Pathological Pathways of Hyperglycemic Damage

  2021cites this paper
• Oral anserine supplementation does not attenuate type-2 diabetes or diabetic nephropathy in BTBR ob/ob mice

  2021cites this paper
• Diabetes and Pancreatic Cancer—A Dangerous Liaison Relying on Carbonyl Stress

  2021influential citation
• Influence of Imidazole-Dipeptides on Cognitive Status and Preservation in Elders: A Narrative Review

  2021cites this paper
• Diabetic Complications and Oxidative Stress: A 20-Year Voyage Back in Time and Back to the Future

  2021cites this paper
• Cardiologist's approach to the diabetic patient: No further delay for a paradigm shift.

  2021cites this paper
• Therapeutic potential of carnosine and its derivatives in the treatment of human diseases.

  2020cites this paper
• Diabetes promotes invasive pancreatic cancer by increasing systemic and tumour carbonyl stress in KrasG12D/+ mice

  2020cites this paper
• L-carnosine and its Derivatives as New Therapeutic Agents for the Prevention and Treatment of Vascular Complications of Diabetes.

  2020cites this paper
• The Inflammasome in Chronic Complications of Diabetes and Related Metabolic Disorders

  2020cites this paper
• AGE-RAGE Axis in the Pathophysiology of Chronic Lower Limb Ischemia and a Novel Strategy for Its Treatment

  2020cites this paper
• Scavenging of reactive dicarbonyls with 2-hydroxybenzylamine reduces atherosclerosis in hypercholesterolemic Ldlr−/− mice

  2019cites this paper
• Carnosine Protects Mouse Podocytes from High Glucose Induced Apoptosis through PI3K/AKT and Nrf2 Pathways

  2019cites this paper
• Effects of β-Alanine Supplementation and Intramuscular Carnosine Content on Exercise Performance and Health

  2019cites this paper
• The advanced glycation endproduct Nε-carboxymethyllysine promotes progression of pancreatic cancer: implications for diabetes-associated risk and its prevention Running title: AGEs as diabetes-related risk factor for pancreatic cancer

  2019cites this paper
• AGE–RAGE stress: a changing landscape in pathology and treatment of Alzheimer’s disease

  2019cites this paper
• LOX-1, the Common Therapeutic Target in Hypercholesterolemia: A New Perspective of Antiatherosclerotic Action of Aegeline

  2019cites this paper
• Inflammation as the common biological link between depression and cardiovascular diseases: Can carnosine exert a protective role?

  2019cites this paper
• A Protocol Outline of Dietary Intervention to Contrast Diabetic Nephropathy

  2019cites this paper
• Carnosine Supplementation Enhances Post Ischemic Hind Limb Revascularization

  2019cites this paper
• New insights into oxidative stress and inflammation during diabetes mellitus-accelerated atherosclerosis

  2018cites this paper
• The advanced glycation end‐product Nϵ‐carboxymethyllysine promotes progression of pancreatic cancer: implications for diabetes‐associated risk and its prevention

  2018cites this paper
• Diet with high content of advanced glycation end products induces systemic inflammation and weight gain in experimental mice: Protective role of curcumin and gallic acid.

  2018cites this paper
• High glucose induces podocyte epithelial-to-mesenchymal transition by demethylation-mediated enhancement of MMP9 expression

  2018cites this paper
• Galectin-3 is essential for proper bone cell differentiation and activity, bone remodeling and biomechanical competence in mice.

  2018cites this paper
• Matrine suppresses AGE‐induced HAEC injury by inhibiting ROS‐mediated NRLP3 inflammasome activation

  2018cites this paper
• FL‐926‐16, a novel bioavailable carnosinase‐resistant carnosine derivative, prevents onset and stops progression of diabetic nephropathy in db/db mice

  2018cites this paper
• l-Carnosine supplementation attenuated fasting glucose, triglycerides, advanced glycation end products, and tumor necrosis factor-α levels in patients with type 2 diabetes: a double-blind placebo-controlled randomized clinical trial.

  2018cites this paper
• Dietary interventions to contrast the onset and progression of diabetic nephropathy: A critical survey of new data

  2018cites this paper
• Carnosine and advanced glycation end products: a systematic review

  2018cites this paper
• Hypertension exaggerates renovascular resistance via miR-122-associated stress response in aging

  2018cites this paper
• Development and validation of a sensitive LC–MS/MS assay for the quantification of anserine in human plasma and urine and its application to pharmacokinetic study

  2018cites this paper
• Role of advanced glycation end products in mobility and considerations in possible dietary and nutritional intervention strategies

  2018cites this paper
• LC-MS-Based Metabolomics and Lipidomics Study of High-Density-Lipoprotein-Modulated Glucose Metabolism with an apoA-I Knockout Mouse Model.

  2018cites this paper
• Natural Food Sources for the Control of Glycemia and the Prevention of Diabetic Complications

  2018cites this paper
• A Review on Diabetes Mellitus: Current Update on Management and Treatment

  2018cites this paper
• On the Relationship between Energy Metabolism, Proteostasis, Aging and Parkinson’s Disease: Possible Causative Role of Methylglyoxal and Alleviative Potential of Carnosine

  2017cites this paper
• Cellular and Molecular Mechanisms of Diabetic Atherosclerosis: Herbal Medicines as a Potential Therapeutic Approach

  2017cites this paper
• Carnosine Attenuates the Development of both Type 2 Diabetes and Diabetic Nephropathy in BTBR ob/ob Mice

  2017cites this paper
• Reactive Carbonyl Species Scavengers—Novel Therapeutic Approaches for Chronic Diseases

  2017cites this paper
• Deficiency of the Purinergic Receptor 2X7 Attenuates Nonalcoholic Steatohepatitis Induced by High-Fat Diet: Possible Role of the NLRP3 Inflammasome

  2017cites this paper
• Therapeutic interventions against accumulation of Advanced Glycation End products ( AGEs )

  2017cites this paper
• The role of human serum carnosinase-1 in diabetic nephropathy

  2016influential citation
• Carnosine and the processes of ageing.

  2016cites this paper
• Evaluation of in vivo hypoglycemic potential of 4-ethyloxychalcone in alloxan-induced diabetic rats

  2016cites this paper
• Catalpol ameliorates diabetic atherosclerosis in diabetic rabbits.

  2016cites this paper
• arnosine and the processes of ageing lan

  2016cites this paper
• Down-Regulation of MicroRNA-137 Improves High Glucose-Induced Oxidative Stress Injury in Human Umbilical Vein Endothelial Cells by Up-Regulation of AMPKα1

  2016cites this paper
• Resveratrol ameliorates high glucose-induced oxidative stress injury in human umbilical vein endothelial cells by activating AMPK.

  2015cites this paper
• Are reactive oxygen species still the basis for diabetic complications?

  2015cites this paper
• Carnosine decreases IGFBP1 production in db/db mice through suppression of HIF-1.

  2015cites this paper
• The protective effects of oral low-dose quercetin on diabetic nephropathy in hypercholesterolemic mice

  2015influential citation
• Measuring AGEs

  2014cites this paper
• IMARS HIGHLIGHTS Research Commentaries for the Members of The International Maillard Reaction Society

  2013cites this paper